In a pharmaceutical, fine chemistry or refining plant, every shift produces material that looks too dirty to be worth anything. Black powder collected in cyclones and baghouse filters. Filter cake removed from the press after a batch. Hydrogenation sludge accumulated in drums. Spent activated carbon. Saturated cartridges. Mats and screens. Dark, contaminated solid, classified as hazardous industrial waste, routed to licensed disposal.
In several cases this material is carrying palladium, platinum, rhodium or ruthenium in commercially relevant amounts — and nobody assayed it.
Where the PGM in the residue comes from
The catalytic processes that most commonly generate PGM-bearing residue:
- Pd/C, Pt/C, Ru/C, Rh/C hydrogenation in pharma and fine chemistry. The metal catalyst is fine particulate dispersed on activated carbon. After use and filtration, the recovered solid carries essentially all the metal of the batch.
- Pt/Rh ammonia oxidation gauzes (HNO₃ production). Gauzes age, particles come loose and end up retained in downstream filters and ducts.
- Reforming and isomerisation with Pt-supported catalysts. Fines pulled from the reactor and trapped in dust collection, condensers, baghouse filters.
- In-house recycling and regeneration operations that mix spent catalyst with process residue, producing sludge of variable grade.
- Purification operations using activated carbon, silica, alumina or molecular sieves. PGM adsorbed onto the solid phase.
Why this residue is under-tested
Pharmaceutical and chemical plants are correctly focused on the main product — API or intermediate. The residue is the EHS team's problem and a contracted disposal cost. In many cases:
- The residue has never been characterised by a recoverable-grade assay.
- Hazardous-waste classification (ABNT, RCRA) talks about toxicity, not value.
- The disposal contract treats material as cost, not as potential asset.
- Regulatory disposal cost can exceed what the material would yield if routed to proper recovery.
Before disposal: what to do
Minimum playbook, in order of cost:
- Catalogue the origin. Which process generated each accumulated lot? Which catalyst was in use, in which reaction, at which scale? Without this, any assay becomes guesswork.
- Do not mix. A Pd/C hydrogenation lot does not go together with oxidation filter cake. Mixing kills the average grade and prevents representative sampling.
- Photo + datasheet. Before any movement, a photo of the lot and a process description. Already enables preliminary technical screening at no analytical cost.
- Volumetric sampling. Powder and cake require representative sampling, not a surface scoop. Simple protocol: several sub-samples at different points, mix, quarter, final aliquot.
- Assay. Preliminary XRF gives direction; ICP-MS or fire assay confirms when the lot justifies it.
What NOT to do
- Do not wet or incinerate the material on your own to "clean it up" or reduce volume. May change PGM chemistry and harm recoverability.
- Do not trust surface XRF without sampling — powder and cake have internal distribution that XRF cannot read without proper preparation.
- Do not sell as generic scrap before at least one assay. Scrap pricing is worst-case pricing for the material.
- Do not delay. Material accumulates, contaminates, mixes. The fresher the lot, the simpler the assay.
What to expect from an assayed lot
There is no universal number. Grade depends entirely on the original catalyst, scale of operation, filtration efficiency and degree of mixing. Some lots carry irrelevant grade and the right path is to confirm via assay and continue with licensed disposal as before. Others surprise.
The point is that the disposal decision becomes informed — not automatic.
Technical page on filter residues →
Have stockpiled material and want screening before the next disposal cycle? Send a photo and process datasheet via the submission form or directly on WhatsApp. Preliminary technical reply on the same business day.